General Information
Drug ID
DR00643
Drug Name
Lansoprazole
Synonyms
lansoprazole; Prevacid; Monolitum; Bamalite; Lansoprazol; Limpidex; Agopton; Ogastro; Opiren; Lanzor; Prevacid SoluTab; Takepron; Lanzopral; Zoton; Lansoprazolum; Lasoprol; Mesactol; Lansopep; Lanproton; Lancid; Ketian; Prezal; Lanston; Aprazol; Blason; Ulpax; Lanz; Pro Ulco; AG-1749; Compraz; Suprecid; Prosogan; Ilsatec; Promp; Zoprol; Dakar; Prevacid Iv; Ogast; Lanzol-30; AG 1749; Lansoprazol [INN-Spanish]; Lansoprazolum [INN-Latin]; Lansox; Lanzo; A-65006; Prevacid NapraPAC; Prevacid 24HR; Lansoprazole [USAN:BAN:INN]; HSDB 7204
Drug Type
Small molecular drug
Indication Peptic ulcer [ICD11: DA61] Approved [1]
Therapeutic Class
Antiulcer Agents
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=3883"></iframe>
3D MOL 2D MOL
Formula
C16H14F3N3O2S
Canonical SMILES
CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
InChI
InChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)
InChIKey
MJIHNNLFOKEZEW-UHFFFAOYSA-N
CAS Number
CAS 103577-45-3
Pharmaceutical Properties Molecular Weight 369.4 Topological Polar Surface Area 87.1
Heavy Atom Count 25 Rotatable Bond Count 5
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 8
XLogP
2.8
PubChem CID
3883
PubChem SID
104179070 , 104234371 , 126682042 , 128604168 , 135156589 , 137931058 , 140767605 , 14901842 , 15375021 , 162189572 , 164178109 , 164761527 , 170503333 , 175265917 , 175269426 , 175611039 , 178102134 , 184527042 , 185965235 , 210274918 , 210280553 , 223658647 , 223798807 , 226429139 , 23998121 , 241033947 , 251879797 , 252151427 , 252431524 , 252811271 , 25819922 , 44715913 , 80665304 , 89736101 , 96025586
ChEBI ID
ChEBI:6375
TTD Drug ID
D06YYD
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Lansoprazole was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 A novel screening strategy to identify ABCB1 substrates and inhibitors. Naunyn Schmiedebergs Arch Pharmacol. 2009 Jan;379(1):11-26.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.